文献
J-GLOBAL ID:201802273953836509
整理番号:18A0436353
間欠的アンドロゲン枯渇療法としての前立腺癌デガレリクス患者におけるオフ治療期間を予測する因子【Powered by NICT】
Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy
著者 (7件):
Abrahamsson Per-Anders
(Department of Urology, Skane University Hospital, Lund University, Malmo, Sweden)
,
Boccon-Gibod Laurent
(Membre de l’Academie de Chirurgie, Expert pres les Tribunaux, Paris, France)
,
Morote Juan
(Department of Urology, Vall d’Hebron Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain)
,
de Jong Igle Jan
(Department of Urology, University Medical Center Groningen, University of Groningen, The Netherlands)
,
Malmberg Anders
(Clinical R&D, Global Biometrics, Ferring Pharmaceuticals, Copenhagen, Denmark)
,
Neijber Anders
(Clinical R&D, Urology, Ferring Pharmaceuticals, Copenhagen, Denmark)
,
Albers Peter
(Department of Urology, Duesseldorf University Hospital, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany)
資料名:
European Urology Focus
(European Urology Focus)
巻:
3
号:
4-5
ページ:
470-479
発行年:
2017年
JST資料番号:
W3084A
ISSN:
2405-4569
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)